William P. Kane Jr - Dec 28, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Commercial Officer
Signature
/s/ Mia Kelley, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Dec 28, 2023
Transactions value $
-$1,210,796
Form type
4
Date filed
12/29/2023, 04:43 PM
Previous filing
Feb 7, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Tax liability -$1.21M -3.83K -21.68% $316.30 13.8K Dec 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the partial vesting of restricted stock units previously granted to the Reporting Person on February 6, 2023.